Travere Therapeutics (TVTX) Exchange Rate Effect (2014 - 2026)
Travere Therapeutics (TVTX) reported Exchange Rate Effect of -$60000.0 for Q1 2026, down 110.95% on a YoY basis from $548000.0 in Q1 2025, and up 85.47% quarter-over-quarter from -$413000.0 in Q4 2025.
Travere Therapeutics (TVTX) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Travere Therapeutics has reported Exchange Rate Effect for 13 years, with the latest figure at -$60000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 110.95% year-over-year to -$60000.0; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 2437.5% YoY), and the FY2025 full-year result was $2.3 million, up 350.93% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$60000.0, up from -$413000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $1.9 million in Q2 2025, with the low at -$1.7 million in Q2 2022.
- Historically, Exchange Rate Effect has averaged $29705.9 across 5 years, with a median of -$60000.0 in 2026.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect slumped 3085.71% — and 2025, when it soared 1888.07%.
- Travere Therapeutics' Exchange Rate Effect stood at $1.1 million in 2022, then increased by 7.89% to $1.2 million in 2023, then sank by 178.31% to -$964000.0 in 2024, then soared by 57.16% to -$413000.0 in 2025, then soared by 85.47% to -$60000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$60000.0 (Q1 2026), -$413000.0 (Q4 2025), and $207000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Travere Therapeutics | 5.07 Bn | 4.99 Bn | 102.38 Mn | -60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Dec 31, 2025 | -413,000.00 |
| Dec 31, 2025 | -413,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Jun 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 548,000.00 |
| Mar 31, 2025 | 548,000.00 |
| Dec 31, 2024 | -964,000.00 |
| Dec 31, 2024 | -964,000.00 |
| Sep 30, 2024 | 453,000.00 |
| Sep 30, 2024 | 453,000.00 |
| Jun 30, 2024 | -109,000.00 |
| Jun 30, 2024 | -109,000.00 |
| Mar 31, 2024 | -293,000.00 |
| Mar 31, 2024 | -293,000.00 |
| Dec 31, 2023 | 1.23 Mn |
| Dec 31, 2023 | 1.23 Mn |